Clinical trial
Evaluation of Platelet-rich Fibrin for Revascularization of Im-mature Permanent Teeth Versus Standard Apexification: a 12-month Clinical Follow-up Study
NCT06693349 is registered in ClinicalTrials.gov with Mohammed Nasser Alhajj as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Platelet-rich Fibrin for Revascularization of Im-mature Permanent Teeth Versus Standard Apexification: a 12-month Clinical Follow-up Study
- Lead sponsor
- Mohammed Nasser Alhajj
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 2, 2020
- Completion date
- April 12, 2021
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
to evaluate the clinical and radiographic effect of platelet-rich fibrin in treatment of necrotic permanent teeth with open apices